STVN
Stevanato Group Spa (STVN)
Healthcare • NYSE • $18.23+1.11%
- Symbol
- STVN
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $18.23
- Daily Change
- +1.11%
- Market Cap
- $4.98B
- Trailing P/E
- 30.38
- Forward P/E
- 21.29
- 52W High
- $28.00
- 52W Low
- $12.89
- Analyst Target
- $24.81
- Dividend Yield
- +0.34%
- Beta
- 0.76
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales servic…
Company websiteResearch STVN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.